Suppr超能文献

利用亲和导向蛋白导弹(AdPROM)系统通过纳米抗体靶向蛋白降解。

Harnessing nanobodies for target protein degradation through the Affinity-directed PROtein Missile (AdPROM) system.

机构信息

Medical Research Council Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, United Kingdom.

Medical Research Council Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, United Kingdom.

出版信息

Methods Enzymol. 2023;681:61-79. doi: 10.1016/bs.mie.2022.08.011. Epub 2022 Sep 13.

Abstract

Targeted protein degradation (TPD) is a useful approach in dissecting protein function and therapeutics. Technologies such as RNA interference or gene knockout that are routinely used rely on protein turnover. However, RNA interference takes a long time to deplete target proteins and is not suitable for long-lived proteins, while a genetic knockout is irreversible, takes a long time to achieve and is not suitable for essential genes. TPD has the potential to overcome the limitations of RNA interference and gene editing approaches. We have established the Affinity directed PROtein Missile (AdPROM) system, which harnesses nanobodies or binders of target proteins to redirect E3 ubiquitin ligase activity to the target protein to induce TPD through the ubiquitin proteasome system. Here we provide a step-by-step protocol for using the AdPROM system for targeted proteolysis of endogenously GFP-tagged K-RAS through an anti-GFP nanobody. This protocol can be amended to target a wide range of different proteins of interest (POIs) either by replacing the anti-GFP nanobody with a nanobody recognising the POI or by endogenously tagging the POI with GFP through CRISPR/Cas9 genome editing.

摘要

靶向蛋白降解(TPD)是一种用于剖析蛋白质功能和治疗的有用方法。RNA 干扰或基因敲除等常规使用的技术依赖于蛋白质周转。然而,RNA 干扰需要很长时间才能耗尽靶蛋白,并且不适合长寿命蛋白,而基因敲除是不可逆的,需要很长时间才能实现,并且不适合必需基因。TPD 有可能克服 RNA 干扰和基因编辑方法的局限性。我们已经建立了 Affinity directed PROtein Missile(AdPROM)系统,该系统利用针对靶蛋白的纳米抗体或结合物将 E3 泛素连接酶活性重定向到靶蛋白,通过泛素蛋白酶体系统诱导 TPD。在这里,我们提供了一个使用 AdPROM 系统通过抗 GFP 纳米抗体对内源性 GFP 标记的 K-RAS 进行靶向蛋白水解的分步方案。可以通过用识别 POI 的抗 GFP 纳米抗体替代抗 GFP 纳米抗体或通过 CRISPR/Cas9 基因组编辑将 POI 内源标记为 GFP 来修改该方案,以靶向广泛的不同感兴趣的蛋白质(POI)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验